Clinical Trial Update: A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma After Progression on Platinum-Based Chemotherapy [Phase 2]

View source ↗

Summary

This update describes a Phase 2 pilot study assessing the safety and clinical activity of Avelumab in patients with thymoma or thymic carcinoma after progressio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thymic Carcinoma
• Thymoma

Drugs mentioned

• Avelumab (avelumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Thymoma, Thymic Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING